Post job

MedAvante-ProPhase's revenue is $9.1 million.

What is MedAvante-ProPhase's revenue?

MedAvante-ProPhase's annual revenue is $9.1M. Zippia's data science team found the following key financial metrics about MedAvante-ProPhase after extensive research and analysis.
  • MedAvante-ProPhase has 350 employees, and the revenue per employee ratio is $26,000.
  • MedAvante-ProPhase peak revenue was $9.1M in 2024.

On this page

Peak revenue
$9.1M (2024)
Company peak revenue
Revenue / employee
$26,000
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Peak revenue
$9.1M (2024)
Company peak revenue
Revenue / employee
$26,000
Company revenue / employee

MedAvante-ProPhase financing

MedAvante-ProPhase received early financing of $20.0M on 2008-07-02.

SeriesRound sizeDate
Series Unknown$20M07/2008
Series Unknown$2M07/2015

MedAvante-ProPhase investors

InvestorsSecurity type
Goldman SachsSeries Unknown
Trevi Health VenturesSeries Unknown

MedAvante-ProPhase competitors

MedAvante-ProPhase's top competitor, NIC, earned an annual revenue of $344.9M.

MedAvante-ProPhase's smallest competitor is Harcourt with revenue of $400.0K last year.

Company nameAverage salaryRevenueEmployee sizeJob openings
Adsystech-$6.1M125-
TownNews-$8.5M150-
NIC-$344.9M901-
VisionAIR-$600,000100-
Solutions-$460,00050-
Source One Management-$7.1M200-
Harcourt-$400,00050-
BMC Group-$130.0M100-
One Technologies-$14.0M556-
RCG Global Services, Inc.-$250.0M1,300-

MedAvante-ProPhase revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of MedAvante-ProPhase, including salaries, political affiliations, employee data, and more, in order to inform job seekers about MedAvante-ProPhase. The employee data is based on information from people who have self-reported their past or current employments at MedAvante-ProPhase. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by MedAvante-ProPhase. The data presented on this page does not represent the view of MedAvante-ProPhase and its employees or that of Zippia.

MedAvante-ProPhase may also be known as or be related to MedAvante, MedAvante Inc and MedAvante-ProPhase.